management of egfr-mutant lung cancer with central nervous system metastases
Published 4 years ago • 802 plays • Length 1:18:11Download video MP4
Download video MP3
Similar videos
-
9:25
volumetric response of brain metastases in egfr mutant nsclc | lisa ni, md
-
17:00
brain metastases in egfr-mutant lung cancer | 2023 living with egfr-mutant lung cancer patient forum
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
2:01
dr balazs halmos: cns metastases in egfrm mnsclc
-
50:55
watch dr. leighl discuss egfr-mutated #nsclc updates from #wclc24 - https://bit.ly/24egfrlungy
-
59:37
refining biomarker testing and targeted treatment of nsclc with egfr mutations
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
2:06
continued use of osimertinib reduces cns metastasis in egfr mutant lung cancer
-
2:03:23
current and future management of non-small cell lung cancer with an egfr mutation
-
45:57
refining precision decisions in nsclc with common and less common egfr mutations
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
3:17
osimertinib in egfr-positive nsclc with brain metastases
-
32:15
a visual exploration of new targeted therapies for egfr exon 20 insertions in nsclc
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
52:36
making precision decisions in the treatment of nsclc with common and uncommon egfr mutations
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
14:23
treatment updates: egfr-mutant lung cancer | 2024 living with egfr-mutant lung cancer patient forum
-
1:53
tops mount sinai: cns metastases treatment in stage iv egfrm nsclc